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1. INTRODUCTION 
Medicinal plants are of great value in the field of treatment and cure of diseases. Over the 
years, scientific research has explained our knowledge of the chemical effects and composition 
of the active constituents. It has now been universally accepted fact that the plant drugs and 
remedies are for safer than that of synthetic medicines for curing the complex diseases. Natural 
product is a source for bioactive compounds and has been a growing interest in drugs of plant 
origin and such drugs formed an important class for disease control.   
History of herbal medicine: 
Plants have been used as a source of medicine by man from ancient times. Initially, these 
formed the bulk of folk or ethno medicines, practiced in India and some other parts of the world 
like China, Africa and South America. Later a considerable part of this indigenous knowledge 
was formulated, documented and eventually passed into the organized system of medicine such 
as Ayurveda, Unani, Siddha and some other outside India. Plants have played a significant role 
in maintaining human health and improving the quality of human life for thousands of years and 
have served human well as valuable components of medicines, seasonings, beverages, cosmetics 
and dyes. Herbal medicine is based on the premise that plant contains natural substances that can 
promote health and alleviate illness. Herbs are prime medicinal agents in traditional and holistic 
therapies. Particularly in India and China an extensive science has been developed. Now a days 
the medicinal plants play a major roll and constitute the back bone of the traditional medicine. 
Mainly in Indian materia medica include about 2000 drugs of natural origin folklore practice. In 
India, plants have been traditionally used for human and veterinary health care. India has a 
special position in area of herbal medicine. Since it is one of the countries which are capable of 
cultivating most of the important plants used both in modern and tradition system of medicine.   
The traditional heritage of India includes many true tested medicinal plants/drugs for 
various diseases and to which there is no answer in modern medicine till today. Indian traditional 
medicine is based on various system including Ayurveda, Siddha, Unani and Homeopathy. The 
Indian traditional medicines can be classified into two groups. In first group are the medicinal 
preparations which are generally of plants, minerals, or animal origin or mixtures of two or three 
of them and have well laid down procedure for their preparations. While the folk medicines 
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belong to the second group, which are herbal house hold remedies and have no systematic 
approach for processing raw materials and are mostly used as family traditions. The evaluation 
of these drugs is primarily based on phytochemical, pharmacological and allied approaches such 
as chromatography, microscopy and other. 
Ayurveda is the ancient system of treatment of a disease consists of salubrious use of 
drugs, diets, and certain practices. Ayurveda is based on hypothesis that everything in the 
universe is composed of five basic elements viz. space, air, energy, liquid and solid. The concept 
of ethno pharmacology has evolved from the requirement for studies in light of modern science 
on the drugs used in the traditional medicine. In 1981, Bruhn and Holmstedt defined ethno 
pharmacology as the interdisciplinary scientific exploration of biologically active agents 
traditionally observed by man. “In its entirety, pharmacology embraces the knowledge of the 
History, source, chemical and physical properties, compounding biochemical and physiological 
effects, mechanism of action, absorption, distribution, biotransformation, excretion and 
therapeutic and other uses of drugs”. A drug is broadly defined as any substance (chemical 
agent) that affects processes of living. Therefore, briefly, the main component of ethno 
pharmacology may be defined as pharmacology of drugs used in ethno medicine. 
Herbalism is a traditional medicinal or folk medicine practice based on the use of plants 
and plant extracts. Herbalism is also known as botanical medicine, medicinal botany. Many 
plants synthesize substances that are useful to the maintenance of health in humans and other 
animals. These include aromatic substances, most of which are phenols of health in humans and 
other animals. These include aromatic substances, most of which are phenols or their oxygen 
substituted derivatives such as tannins. Many of the herbs and spices used by humans to season 
food yield useful medicinal compounds. Many of the pharmaceutical currently available to 
physicians have a long history of use as herbal medicines, including opium, aspirin, digitalis, and 
quinine. 
The World Health Organization (WHO) estimated that about 80% of the population 
living in the developing countries relies almost exclusively on tradition medicine, the medicine 
for their primary health care needs. In almost all the traditional medicine the medicinal plants 
play a major role in cure of disease. The plant kingdom still holds many species of plants 
containing substance of medicinal value which have yet to be discovered large no of plants are 
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constantly being screened for their possible pharmacological value. All plants possess hundreds 
of characteristics of a morphological, histological, embryological, chemical and genetic nature. 
Currently, photo chemistries have significant development. The technology involves the 
isolation, extraction, Purification and characterization of active constituents from natural origin. 
The isolated compounds are mainly used as therapeutic agent in chronic disease.   
According to the WHO, 74% of 119 modern plant- derived pharmaceutical medicines are 
used in ways that are similar to their traditional uses. Major pharmaceutical companies are 
currently conducting extensive research on plant materials gathered from the rainforests and 
other places for possible new pharmaceuticals. Nature can be considered as the ultimate chemist 
as natural products offer us with an abundant source of novel chemo-types, pharmacophores or 
lead structures, which could be directly used or derived into ready-made drugs.  
“Herbal renaissance” is happening all over the globe as herbal products are the symbol of 
safety as compare to synthetic medicine, which could be regarded unsafe to human and 
environment. From many centuries herbs are used for a medicinal, flavoring and aromatic 
properties but synthetic products of modern age has decreased their importance for a movement. 
But hopefully blind dependence on synthetic drug is over and now day’s peoples are adopting 
herbalism with hope of security and safety to health.  
Traditional system of medicine is found to have utilities as many accounts. Due to 
population rise adequate supply of drug and high cost of treatment and side effect along with 
drug resistance has been encountered in synthetic drugs, which has lead to an elevated emphasis 
for the use of plants to treat human diseases. The affordability of herbs has also drawn the 
attraction towards their use. 
India is one of the oldest civilizations which is known for rich repository of medicinal. 
The forest of India is Pandora’s Box being having rich collection of medicinal and aromatic 
plants which could be utilize to prepare drugs and perfumes. Ayurveda, the bible of Indian 
medicinal science has codified about 8000 herbal remedies used for various therapeutic 
purposes. The other ancient epical health books like, The Rig-Veda, Yajurveda, Atharvaveda, 
Charaka Samhita and Sushrut samhita has described the use of various medicinal plants which 
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are still found in many of Ayurveda formulations. But unfortunately a lot of valuable ancient 
knowledge is being lost in alarming rate. 
Green plants biosynthesize and preserve large number of biochemical products, many of 
which are extractable and used for various scientific investigations. Secondary metabolites of 
plants also found a number of roles in modern medicine. It is the potential of ancient herbal 
medicinal systems which provide base to synthesis the lead structures for the development of 
modified derivatives with increased efficiency and/or reduced toxicity. 
Some miraculous useful chemical from plants include vincristine, vinblastine, 
taxolpodophyllotoxin, camptothecin, digitoxigenin, gitoxigenin, digoxigenin, tubocurarine, 
morphine,codeine, aspirin, atropine, pilocarpine, capsaicin, allicin, curcumin, artemesinin and 
ephedrine. The crude extract from medicinal plants could be used as medicament. In the other 
side, the isolation and identification of active principle along with elucidation of their mechanism 
of action of drug extreme importance. 
In industrialized nations at the present time, some fifty percent of all prescribed drugs are 
derived or synthesized from natural products, the available sources for which are animals, 
marine, plants, and micro-organisms. It is considered that because of the structural and biological 
diversity of their constituents, terrestrial plants offer a unique and renewable source. 
1. Peptic Ulcer Disease 
Peptic ulcer disease refers to pathological lesions and ulcers of any portion of 
gastrointestinal tract exposed to acid activated pepsin.  Peptic ulcer disease (PUD) differs from 
gastritis and erosions in that ulcers typically extend deeper into the muscular is mucosa.  There 
are three common forms of peptic ulcers:  Helicobacter pylorus (H. pylori) associated Non-
steroidal anti-inflammatory drug (NSADI) Induced, and stress ulcers.  The term “Stress-related 
mucosal damage” (SRMD) is preferred to stress ulcer or stress gastritis, because the mucosal 
lesions range from superficial gastritis and erosions to deep ulcers.  Gastric ulcer refers to ulcer 
in the stomach where as duodenal ulcer is an ulcer found in duodenum of small intestine. 
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Peptic ulcer is one of the major health problem both in terms of morbidity and in terms of 
mortality.   Research advances have offered new sights in the the therapy and prevention of 
gastro duodenal ulcerations by measures directed at strengthening the mucosal defense systems 
rather than by attenuating aggressive acid pepsin factors held responsible for the induction of 
ulcers.  Most of the peptic ulcers are duodenal in nature.  The cause of ulceration in patients is 
mainly due to hyper-secretion of gastric juice and pepsin.  The other forms of peptic ulcers are 
Zollinger-Elllison syndrome, drug associated ulcers and stress ulcers. 
Treatment options available are use of muco protective agents, antacids, alginates, 
motility stimulants and acid suppressants.  Anti reflux surgery is done in severe cases.  In spite of 
established anti-ulcer drugs, a rational therapy for peptic ulcer remains elusive and search for 
safer potential drugs is being carried out.  
1.1 Definitions 
 An ulcer is a local defect, or excretion of the surface of an organ or tissue that is produced 
by the sloughing (shedding) of inflammatory necrotic tissue. 
 Ulcers are local defect on the surface of an organ produced by inflammation. 
 An Ulcer is a discontinuity of the skin exhibiting complete loss of the epidermis and often 
portions of the dermis. 
 Ulceration is the process of ulcer formation and the process of becoming ulcerated.  An 
open sore on the skin surface or on the stomach lining.  An open sore on the skin or 
mucous membrane characterized by the disintegration of the tissue and often the discharge 
of pus. 
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Fig1. Peptic ulcer disease 
 
                                       
Peptic ulcer is a breach in the gastric and duodenal epithelium associated with acute or 
chronic inflammation. Peptic ulcer is the most common gastro intestinal disorder in clinical 
practice. Gastric ulcer refers to ulcer in the stomach whereas duodenal ulcer is an ulcer found in 
duodenum of small intestine (Jain et al .,1994).  
1.2 Types of peptic ulcer  
 Acute (Stress) peptic ulcer 
 Acute peptic ulcer are multiple, small mucosal erosion, seen commonly in the stomach 
but occasionally involving the duodenum. 
Etiology- 
The Acute ulcers occur due to severe stress. The causes are as follows: 
 Psychological stress. 
 Physiological stress. 
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Physiological stress as in the following: 
 Shock and severe trauma 
 Septicemia 
 Expensive burns 
 Drug intake (Aspirin, Steroids and Indomethacin). 
 Local irritants (Alcohol, Smoking, Coffee). 
 Chronic Peptic Ulcer 
Chronic ulcer are also two types either Gastric or duodenal. 
Etiology-    
Chronic ulcer may be caused by 
 Helicobacter pylori 
 About 15-20% cases infected with H.Pylori develops duodena ulcer in their life time while 
gastric colonization by H.Pylori never develops ulceration and remain asymptomatic. 
 Aspirin and other salicylates damage the gastric mucosa precipitates   
 Upper gastro intestinal bleeding and cause gastric ulcer. 
Numerous mechanisms whereby aspirin and salicylates damage the mucosa have been 
suggested the most important of which is their ability to inhibit prostaglandins synthesis. 
 Acid-Pepsin in secretion 
There is convulsive evidence that some level of acid-pepsin secretion is essential for the 
development of duodenal as well as gastric ulcer. 
 Mucous secretion 
Any condition that decreases the quantity of normal protective mucous “barrier” predisposes 
to the development of peptic ulcer. 
 Dietary factor nutritional deficiencies have been regarded as etiological factor in peptic ulcer. 
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 Psychological factor 
Psychological stress, anxiety, fatigue, and ulcer type personality may exacerbate as well as 
predispose to peptic ulcer disease. 
 Local irritants 
Some of the local irritating substances implicated in the etiology of peptic ulcer are: 
1. Smoking: Cigarette smoking can increase a person’s chance of getting an ulcer. Smoking 
also slows the healing of existing ulcers and contributes to ulcer recurrence. 
2. Caffeine: Beverages and foods that contain caffeine can stimulate acid secretion in the 
stomach. This can aggravate an existing ulcer, but the stimulation of stomach acid can’t be 
attributed solely to caffeine. 
3. Alcohol: Alcohol consumption increases the risk of peptic ulcer ( Harsh Mohan,2005). 
  
1.3 Complications of peptic ulcer 
Some initial complications or symptoms of peptic ulcer disease. 
 Bleeding: Bleeding may be the first and only symptom of an ulcer. Bleeding ulcers can 
cause vomiting of acidified blood that looks like “old coffee grounds”or bowel 
movements can become tarry black or even bloody. When an ulcer bleeds and continues 
to bleed without treatment, a person may become anemic. 
 Perforation: When ulcers are untreated, gastric juices can literally eat a hole in (perforate) 
the stomach lining, requiring surgery. 
 Obstruction: chronic inflammation from an ulcer can cause swelling and scarring. Over 
time, this scarring may close (obstruct) the outlet of the stomach, preventing the passage 
of food and causing vomiting and weight loss. Surgery is required to repair obstructions 
(Harsh Mohan, 2005; Al-Mofleh et al.,2006).   
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1.4 Most common types of Ulcers 
 Peptic Ulcer: Any ulcer that is exposed to pepsin is referred  to as peptic ulcers.  Peptic 
ulcers are found in the lining of your stomach or duodenum.  Pepsin is normally present 
along with hydrochloric acid in the stomach lining. 
 Gastric Ulcer : When a peptic ulcer is in stomach, it is called a gastric ulcer. 
 Doudenal Ulcer: When a peptic ulcer is in duodenum, it is called a duodenal ulcer.  This 
type of peptic ulcer develops in the first part of the small intestine. 
  
Lesser types of ulcers 
 Esopohageal Ulcer: This type of ulcer occurs in the lower and of your esophagus.  
Esophageal ulcersare often associated with an acid reflux, or GERD (Gastro Esophageal 
Reflux Disease). 
 Bleeding Ulcer: Internal bleeding is caused by apeptic ulcer which has been left 
untreated.  When this happens, it is now refered to as a bleeding ulcer – this is the most 
dangerous type of ulcer. 
 Refractory Ulcer: Refractory ulcers are simply peptic ulcers that have not healded after 
at least 3 months of treatment. 
 Stress ulcer: Stress ulcers are a group of lesions (or lacerations) found in the esophagus, 
stomach or duodenum. 
1.5 Causes of ulcer 
The direct cause of peptic ulcers is the destruction of the gastric or intestinal mucosal 
lining of the stomach by hydrochloric acid, an acid normally present in the digestive juices of the 
stomach. 
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The causes by which ulcer from are following:- 
 Helicobacter pylori infection, a spiral shaped type of bacteria, is present in more than 
90% of patients who have intestinal ulcers and more than 80% of patients with stomach 
ulcers. 
 Helicobacter pylorus weakens the protective mucous coating of the stomach and 
duodenum which allows acid to get through to the sensitive lining beneath.  Both the acid 
and the bacteria irritate the lining and cause a sore, or ulcer.  
 Long term use of anti-inflammatory drugs (NSAIDs) or pain relievers such as aspirin, 
ibuprofen, and naproxen sodium.  NSAIDs lower the stomach’s resistance to the harmful 
effects of acid. 
 Smoking.  
 Physical Stress such as surgery or extreme injury.  Emotional stress is no longer thought 
to be a cause of ulcers.  
 Alcohol. 
 Stress and diet can irritate an ulcer, they do not cause it.  
 Ulcers can be cured with a one or two week course of antibiotics, even for people who 
have had ulcers for years.  
 Excess alcohol consumption.  
 Improper diet, irregular or skipped meals. 
 Zollinger-Ellison syndrome (hyper-secretory state). 
 Chronic disorders such as liver disease, emphysema, rheumatoid arthritis may increase 
ulcers. 
 Abdominal discomfort is the most common symptom. 
 Chronic disorders such as liver disease, emplysema, rheumatoid arthritis may increase 
ulcers.  
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1.6 Symptoms of ulcer  
The major symptom of an ulcer is a burning or gnawing feeling in the stomach.  This pain 
is often interpreted as heartburn, indigestion or hunger.  The pain usually occurs in the upper 
abdomen, but sometimes it may occur below the breastbone.  In some individuals the pain occurs 
immediately after eating. Symptoms are:  
 Weight loss 
 Poor appetite 
 Bloating 
 Burping 
 Nausea 
 Vomiting 
 Sharp, Sudden, persistent stomach pain 
 Bloody or black stools 
 Bloody vomit or vomit that looks like coffee grounds 
 Bleeding, when acid or the ulcer breaks a blood vessel  
 
1.7. Epidemiology  
Approximately 10% of Americans develop chronic PUD during their lifetime.  The 
incidence varies with ulcer type, age, gender, and geographic location.  Race, occupation, genetic 
predisposition, and societal factors may play a minor role in ulcer pathogenesis, but are 
attenuated by the importance of H. pylori infection and NSAID use.  The prevalence of PUD in 
the United States has shifted from predominance in men to nearly comparable prevalence in men 
and women.  Recent trends suggest a declining rate for younger men and an increasing rate for 
younger men and an increasing rate for older women. Factors influencing these trends include 
the declining smoking rates in younger men and the increased use of NSAIDs in older adults. 
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1.8 Risk Factor 
Most peptic ulcers occur in the presence of acid and pepsin when Pylori, NSAIDs, or 
other factors disrupt normal mucosal defense and healing mechanisms.  Hyper secretion of acid 
is the primary pathogenic mechanism in hyper secretary states such as ZES.  Ulcer locations are 
related to a number of etiologic factors.  Benign gastric ulcers can occur anywhere in the 
stomach although most are located on the lesser curvature, just distal to the junction of the astral 
and acid-secreting mucosa.  Most duodenal ulcers occur in the first part of the duodenum. 
1.9 Pathophysiology 
A physiologic imbalance between aggressive factors (gastric acid and pepsin) and 
protective factors (mucosal defense and repair) remain important issues in the Pathophysiology 
of gastric and duodenal ulcers.  Gastric acid is secreted by the parietal cells, which contain 
receptors for histamine, gastrin, and acetylcholine.  Acid (as well as H. pylori infection and 
NSAID use) is an independent factor that contributes to the disruption of mucosal integrity.  
Increased acid secretion has been observed in patients with duodenal ulcers and may be a 
consequence of H. pylori infection.  Patients with ZES have profound gastric acid hyper 
secretion resulting from a gastrin producing tumor.  
Patients with gastric ulcer usually have normal or reduced rates of acid secretion 
(hypochlorhydria).  Pepsin is an important cofactor that plays a role in the proteolytic activity 
involved in ulcer formation.  
Pepsinogen, the inactive precursor of pepsin, is secreted by the chief cells located in the 
gastric fundus.  Pepsin is activated by acid pH (optimal pH of 1.8 to 3.5), inactivated reversibly 
at pH, and irreversibly destroyed at pH7.  Mucosal defense and repair mechanisms (mucus and 
bicarbonate secretion, intrinsic epithelial cell defense, and mucosal blood flow) protect the gastro 
duodenal mucosa from noxious endogenous and exogenous substances.  
The viscous nature and near-neutral pH of the mucus-bicarbonate barrier protect the 
stomach from the acidic contents in the gastric lumen.  Mucosal repair after injury is related to 
epithelial cell restitution, growth, and regeneration.  The maintenance of mucosal integrity and 
repair is mediated by the production of endogenous prostaglandins.  The term cytoprotection is 
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often used to describe this process, but mucosal defense and mucosal protection are more 
accurate terms, as prostaglandins prevent deep mucosal injury and not superficial damage to 
individual cells.  Gastric hyperemia and increased prostaglandin synthesis characterize adaptive 
cytoprotection, the short-term adaptation of mucosal cells to mild topical irritants.  This 
phenomenon enables the stomach to initially withstand the damaging effects of irritants.  
Alterations in mucosal defense that are induced by H. pylori or NSAIDs and the most important 
co factors in the formation of peptic ulcers.  
1.10 Physiology of Ulcer 
Gastric acid secretion is a complex, continuous process in which multiple central and 
peripheral factors contribute to a common end point: the secretion of H+ by parietal cells.  
Neuronal (acetylcholine, Ach), paracrine (histamine), and endocrine (gastrin) factors all regulate 
acid secretion.  Their specific receptors (M3, H2, and CCK2 receptors, respectively) are on the 
basolateral membrane of parietal cells in the body and fundus of the stomach.  The H2 receptor is 
a GPCR that activates the Gs- adenylylcyclase-cyclic AMP-PKA pathway.  ACh and gastrin 
signal through GPCRs that couple to the Gq-PLC-IP3-Ca2+ pathway in parietal cells.  In parietal 
cells, the cyclic AMP and the Ca2+ - dependent pathways activate H+,K+-ATP ase (the proton 
pump), which exchanges hydrogen and potassium  ions across the parietal cell membrane.  
This pump generates the largest known ion gradient in vertebrates; with an intracellular 
pH of about 7.3 and an intracanalicular pH of about 0.8.  The most important structures for CSN 
stimulation of gastric acid secretion are the dorsal motor nucleus of the vagal nerve, the 
hypothalamus, and the solitary tract nucleus.  Efferent fibers originating in the dorsal motor 
nuclei descend to the stomach via the vagus nerve and synapse with ganglion cells of the enteric 
nervous system.  ACh release from postganglionic vagal fibers directly stimulates gastric acid 
secretion through muscarinic M3 receptors on the basolateral membrane of parietal cells.  
 
The CNS predominantly modulates the activity of the enteric nervous system via ACh, 
stimulating gastric acid secretion in response to the sight, smell, taste, or anticipation of food (the 
“cephalic” phase of acid secretion).  ACh also indirectly affects parietal cells by increasing the 
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release of histamine from the enterochromaffin-like (ECL) cells in the fundus of the stomach and 
of gastrin from G cells in the gastric antrum.  
ECL cells, the source of gastric histamine secretion, usually are in close proximity to 
parietal cells.  Histamine acts as a paracrine mediator, diffusiong frim its site of release to nearby 
parietal cells, where it activates H2 receptors.  The critical role of histamine in gastric acid 
secretion is dramatically demonstrated by the efficacy of H2-receptor antagonists in decreasing 
gastric acid secretion.  
Gastrin, which is produced by antral G cells, is the most potent inducer of acid secretion. 
Multiple pathways stimulate gastrin release, including CNS activation, local distension, and 
chemical components of the gastric contents. Gastrin stimulates acid secretion indirectly by 
inducing the release of histamine by ECL cells; a direct effect on parietal cells also plays a lesser 
role.  
Somatostation (SST), which is produced by antral D cells, inhibits gastric acid secretion.  
Acidification of the gastric luminal pH to <3 stimulates SST release, which in turn suppresses 
gastrin release in a negative feedback loop.  SST-producting cells are decreased in patients with 
H. pylori infection, and the consequent reduction of SST’ inhibitory effect may contribute to 
excess gastrin production.  
1.11 Regulation of Gastric Acid Secretion (Goodman, Gillman, 2006)  
Gastric acid secretion by parietal cells of the gastric mucosa is stimulated by 
acetylcholine, histamine, and gastrin.  The receptor-mediated binding of acetylcholine, 
histamine, or gastrin results in the activation of protein kinases, which in turn stimulates the 
H+/K+ adenosine triphosphatase (ATPase) proton pump to secrete hydrogen ions in exchange for 
K+ into the lumen of the stomach.  A Cl- channel couples chloride efflux to the release of H+. In 
contrast, receptor binding of prostaglandin E2 and somatostatin diminish gastric acid production.  
[Note: Histamine binding causes activation of adenylylcyclase, whereas binding of prostaglandin 
E2 inhibits this enzyme.  Gastrin and acetylcholine act by inducing an increase in intracellular 
calcium levels.  
15 
 
                     
 
                                 Fig 2. Regulation of Gastric Acid Secretions 
1.12 Gastric Defense against Acid 
The extremely high concentration of H+ in the gastric lumen requires robust defense 
mechanisms to protect the esophagus and the stomach.  The primary esophageal defense is the 
lower esophageal sphincter, which prevents reflux of acidic gastric contents into the esophagus.  
The stomach protects itself from acid damage by a number of mechanisms that require adequate 
mucosal blood flow, perhaps because of the high metabolic activity and oxygen requirements of 
the gastric mucosa.  One key defense is the secretion of a mucus layer that protects gastric 
epithelial cells.  Gastric mucus is soluble when secreted but quickly forms an insoluble gel that 
coats the mucosal surface of the stomach, slows ion diffusion, and prevents mucosal damage by 
macromolecules such as pepsin.  
 
16 
 
Mucus production is stimulated by prostaglandins E2 and I2, which also directly inhibit 
gastric acid secretion by parietal cells.  Thus, alcohol, aspirin, and other drugs that inhibit 
prostaglandin formation decrease mucus secretion and predispose to the development of acid-
peptic disease.  A second important part of the normal mucosal defense is the secretion of 
bicarbonate ions by superficial gastric epithelial cells.  Bicarbonate neutralizes the acid in the 
region of the mucosal cells, thereby raising pH and preventing acid-mediated damage. (Goodman 
Gillman-2006). 
2. Treatment 
2.1 Proton Pump Inhibitors 
Chemistry, Mechanism of Action & Pharmacology  
The most potent suppressor of gastric acid secretion are inhibitors of the gastric H+, K+-
ATP ase (proton pump).  In typical doses, these drugs diminish the daily production of acid 
(basal and stimulated) by 80% to 95%.  Five proton pump inhibitors are available for clinical 
use: omeprazole (PRILOSEC, RAPINEX and ZEGERID), and its S-isomer, esomeprazole 
(NEXIUM), lansoprazole (PREVACID), rabeprazole (ACIPHEX), and pantoprazole 
(PROTONIX).  These drugs have different substitutions on their pyridine and/or benzimidazole 
groups but are remarkably similar in their pharmacological properties.  Omeprazole is a racemic 
mixture of R- and S- isomers; the S-isomer, esomeprazole (S-omeprazole), is eliminated less 
rapidly than R-omeprazole, which theoretically provides a therapeutic advantage because of the 
increased half-life.  Despite claims to the contrary, all proton pump inhibitors have equivalent 
efficacy at comparable doses.  
Proton pump inhibitors are pro drugs that require activation in an acid environment.  
After absorption into the systemic circulation, the pro drug diffuses into the parietal cells of the 
stomach and accumulates in the acidic secretary canaliculi. Here, it is activated by proton-
catalyzed formation of a tetracyclic sulphonamide, trapping the drug so that it cannot diffuse 
back across the canalicular membrane.  
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The activated from then binds covalently with sulfhydry1 groups of cysteine’s in the 
H+,K+ - ATP ase, irreversibly inactivating the pump molecule.  Acid secretion resumes only after 
new pump molecules are synthesized and inserted into the luminal membrane, providing a 
prolonged(up to 24 to 48 hour) suppression of acid secretion, despite the much shorter plasma 
half-lives (0.5to 2 hours) of the parent compounds.  Because they block the final step in acid 
production, the proton pump inhibitors are effective in acid suppression regardless of other 
stimulating factors. 
To prevent degradation of proton pump inhibitors by acid in the gastric lumen, oral 
dosage forms are supplied in different formulations; 
1. enteric-coated drugs contained inside gelatin capsules (omeprazole, esomeoprazole, and 
lansoprazole) 
2. enteric-coated granules supplied as a power for susopension (lansoprazole) 
3. Enteric-coated tables (pantoprazole, rabeprazole, and omeprazole) 
4. Powdered drug combined with sodium bicarbonate (omeprazole) 
The delayed-released and enteric-coated tablets dissolve only at alkaline pH, while 
admixture of omeprazole with sodium bicarbonate simply neutralizes stomach acid; both 
strategies substantially improve the oral  
Bioavailability of these acid -labile drugs.  Until recently, the requirement for enteric 
coating posed a challenge to the administration of proto pump inhibitors in patients for whom the 
oral route of administration is not available.  These patients and those requiring immediate acid 
suppression now can be treated parent rally with pantoprazole or lansoprazole, both of which are 
approved from intravenous administration in the United States.  
A single intravenous bolus of 80 mg of pantoprazole inhibits acid production by 80% to 
90% within an hour, and this inhibition persists for up to 21 hours, permitting once-daily dosing 
to achieve the desired degree of hypochlorhydria.  The FDA approved does of intravenous 
pantoprazole for gastroesophageal reflux disease in 40mg daily for up to 10 days Higher doses 
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(e.g. 160 to 240 mg in divided does) are used to manage hyper secretary conditions such as the 
Zollinge r-Ellison syndrome. 
2.2  H2-Receptor Antagonists 
Chemistry, Mechanism of Action & Pharmacology 
The H2-recptor antagonists inhibit acid production by reversibly competing with 
histamine for binding to H2 receptors on the basolateral membranes of parietal cells.  Four 
different H2  receptor antagonists, which differ mainly in their pharmacokinetic s and propensity 
to cause drug interactions, are available in the United States: cimetidine (TAGAMENT), 
ranitidine (ZANTAC), famotidine  (PEPCID), and nizatidine (AXID).  These drugs are less 
potent than proton pump inhibitors but still suppress 24 hour gastric acid secretion by about 70% 
the H2 receptor antagonists predominantly inhibit basal acid secretion, which accounts for their 
efficacy in suppressing nocturnal acid secretion.  
2.3  Prostaglandin analogues: 
Misoporostol 
Prostaglandin E2 (PG E2) and prostacyclin (PG I2) are the major prostaglandins 
synthesized by the gastric mucosa.  They bind to the EP3 recepto on parietal cells) and stimulate 
the Gi pathway, thereby decreasing intracellular cyclic AMP and gastric acid secretion.  PG E2 
also can prevent gastric injury by cytoprotective effects that include stimulation of mucin and 
bicarbonate secretion and increased mucosal blood flow.  Although smaller does than those 
required for acid suppression can protect the gastric mucosa in laboratory animals, this has not 
been convincingly demonstrated in humans; acid suppression appears to be the most important 
effect clinically.  Since NSAIDs diminish prostaglandin formation by inhibiting cyclooxygenase, 
synthetic prostaglandin analogues offer a logical approach to reducing NSAID in duced mucosal 
damage. 
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Sucralfate :  
In the presence of acid-induced damage, pepsin-mediated hydrolysis of mucosal proteins 
contributes to mucosal erosion and ulcerations.  This process can be inhibited by sulphated 
polysaccharides.  Sucralfate (CARAFATE) consists of the octasulfate of surcrose to which A1 
(OH)3 has been added.  In an acid environment (pH 4), sucralfate undergoes extensive cross-
linking to produce a viscous, sticky polymer that adheres to eopithelial cells and ulcer creaters 
for up to 6 hours after a single does.  In addition to inhibiting hydrolysis of mucosal proteins by 
pepsin, surcralfate may have additional cytoprotective effects, including stimulation of local 
production of prostaglandins and epidermal growth factor.  Surcralfate also binds bile salts; thus, 
some clinicians use surcralfate to treat individuals with the syndromes of biliary esophagitis or 
gastritis (the existence of which is controversial). 
 
Antacids: 
The antacids largely have been replaced by more effective and convenient drugs.  
Nevertheless, they continue to be used by patients for a variety of indications, and some 
knowledge of their pharmacology is important for the medical professional.  Many factors, 
including palatability, determine the effectiveness and choice of antacid.  Although sodium 
bicarbonate effectively neutralizes acid, it is very water-soluble and rapidly absorbed from the 
stomach, and the alkali and sodium loads may pose a risk for patients with cardiac or renal 
failure. Depending on particle size and crystal structure, CaCO3 rapidly and effectively 
neutralizes gastric H+, but the release of CO2 from bicarbonate-and carbonate-containing 
antacids can cause belching, nausea, abdominal distension, and flatulence.  Calcium also may 
induce rebound acid secretion, necessitating more frequent administration.  Combinations of 
Mg2+ (rapidly reacting) and A13+ (slowly reacting) hydroxides provide a relatively balanced and 
sustained neutralizing capacity and are preferred by most experts. 
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Magaldrate:  
Is a hydroxyl magnesium aluminates complex that is converted rapidly in gastric acid to 
Mg (OH)
 2 and A1 (OH) 3, which are absorbed poorly and thus provide a sustained antacid effect.  
Although fixed combinations of magnesium and aluminum theoreticlly counteract the adverse 
effects of each other on the bowel (Al3+ can relax gastric smooth muscle, producing delayed 
gastric emptying and constipation, while Mg2+ exerts the opposite effects), such balance is not 
always achieved in practice.  
Simethicone, is a surfactant that may decrease foam and hence oesophageal reflux is 
included in many antacid preparations.  However, other fixed combinations, particularly those 
with aspirin, that are marketed for  “acid indigestion” are irrational choices, are potentially 
unsafe in patients predisposed to gastro duodenal ulcers, and should not be used. 
2.4 Other Acid Suppressants and Cytoprotectants 
 The M1 muscrainic receptor antagonists pirenzepine and telenzepine can reduce basal 
acid production by 40% to 50% an long have been used to treat patients with peptic ulcer disease 
in countries other than the United State.  The Ach receptor on the parietal cell itself is of the M3 
subtype, and these drugs are believed to suppress neural stimulation of acid production via 
actions on M1 receptors of intramural ganglia.  Because of their relatively poor efficacy, 
Significant and undesirable anticholinergic side effects, and risk of blood disorder (pirenzepine), 
they rarely are used today. 
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2. LITERATURE REVIEW 
J. Megalal, A. Geetha et al, 2010 evaluated the gastroprotective effect of hydroalcoholic fruit 
Extract of Pithecellobium dulce (HAEPD) in the injury of rat gastric mucosa induced by absolute 
ethanol and as well as to elucidate the role of reactive oxygen species. 
 
M. Sugumaran et al, 2008 studied the study Locomotor activity of aqueous and alcoholic 
extracts of leaves of Pithecellobium dulce Benth.   
M. Sugumaran et al, 2006 studied the macroscopical characters of the leaves, leaf constants, 
physico-chemical constants, extractive values, colour, consistency, pH, extractive values with 
different solvents.  
P. Ponmozhi et al, 2011 investigated the beneficial role of anthocyanin extracted from 
Pithecellobiumdulce fruit percarp. 
V.S. Mule et al, 2011 were undertaken to evaluate several neuropharmacological activities of the 
aqueous and ethanolic extracts of Pithecellobium dulce Benth (Leguminosae)  Leaves in swiss 
albino mice.   
N. Ramam et al, 2012 reported a green chemistry approach for the biological synthesis of silver 
nanoparticles using the aqueous leaf extract of Pithecellobiumdulce, which acts as a reducing and 
capping agent. 
M. Sugumaran et al, 2009 studied the Ethanolic and aqueous leaf extract of Pithecellobium 
dulce for its antidiabetic activity using streptozotocin-induced diabetic model in rats.   
Parasenjit Manna et al, 2001 have carried out to investigate the protective role of the aqueous 
extract of the fruits of P. dulce (AEPD) against CC14-induced hepatic disorders.  
J. Ravikumar et al, 2008 were carried out to determine the effect of methanolic extract of 
Anisochilus carnosus leaves for antiulcer, gastric antisecretory and cytoprotective effect in 
pylorus ligated rats. 
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V. Tandon et al, 2011 have reviewed This paper reviews the present state of knowledge 
regarding the use of some traditional medicinal plants in curing worm infections in different 
regions of the world, with particular reference to north-east India. 
M. Sugumaran et al, evaluated the aqueous and alcoholic extract of Pithecellobium dulce leaves  
for radical scavenging activity using reducing power assay method.   
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3.   PLANT PROFILE 
  
             
Fig:3 Pithecellobium dulce fruit 
                 
Fig: 4 Pithecellobium dulce seeds 
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The Earlier Reports on the Pharmacognostical, Phytochemical, Pharmacological, and 
Microbial Studies on Pithecelloium dulce Listed Below. 
Botanical Information   
            Synonym(S):  Inga Dulcis (Rox B.)Wild 
                                     Mimosa Dulcis Rox  B. 
Taxonomical Classification 
           Kingdom:                                   Plantae  
           Sub Kingdom:                            Tracheobionta  
           Division:                                     Magnoliophyta  
           Class:                                          Magnoliopsida  
           Subclass:                                    Rosidae  
           Order:                                        Fabales  
           Family:                                      Fabaceae  
           Sub Family:                              Mimosoideae  
           Tribe:                                       Ingeae  
           Genus:                                     Pithecelloboum  
           Species:                                   P.dulce       
Vernacular Name: ( Agroforestry Tree Database) 
Arabic                                 Tamar Hindi 
Bengali                               Amil Dekhani Babul 
English                               Madras Thorn, Manila Tamarind 
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Hindi                                  Jangal Jelbi, Dakhani Babul 
Indonesian                          Asam Koranji 
Malay                                 Asam Kranji   
Spanish                               Guama Americano 
Tamil                                  Kodukapuli 
Plant Descripton 
A small to medium – sized semi evergreen shrub or tree reaching 5-20 m. In height, with 
a short trunk. The tree is broadly crowned and the trunk is often crooked or has low branches. 
Seeds: 
Pods are 10-15 X 1.5 Cm; The Color Becoming Reddish Brown As They Ripen . Each 
Pod Contains 5-10  Shiny Black Seeds Up To 2 Cm Long. 
Distribution: 
               Native:  Argentina, Bolivia, Brazil, United States Of America, Mexico 
               Exotic:   Cambodia, China, Cuba, India, Indonesia, Jamaica, Philippines. 
Phytochemical Constituents: 
 Seeds have been reported to contain Steroids, Saponins, Lipids, Phospholipids, 
Glycosides, Glycolipids And Polysaccharides. 
Medicinal Uses:       
 Frequent Bowel Movements: Decoction of bark taken as tea. 
 The Leaves, when applied as plasters, used for pain, venereal sores. 
 Salted Decoction of Leaves for indigestion; also used as abortifacient. 
 Bark used in dysentery, dermatitis and eye Inflammation. 
 In Brazil, P. avaremotem, used as a Cancer Elixer. 
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                                  4. AIM AND OBJECTIVE OF THE STUDY 
 
 The aim of present study is to evaluate Anti-ulcer activity of Pithecellobium dulce seed 
extracts by pylorus ligation method in Albino Wistar strain rats. 
 
 Many plants showing Anti-ulcer activity is due to the presence of antioxidants, 
Pithecellobium dulce seeds has not been explored for the Anti-ulcer Activity but the plant 
possess antioxidant activity according to the phytochemistry and pharmacological properties of 
Pithecellobium dulce an overview. Hence my objective and my future work were concentrated 
on the Anti-ulcer activity of Pithecellobium dulce seeds. 
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5. PLAN OF WORK 
 5.1 preliminary work 
 Literature survey 
 Plant selection 
 Authentication 
 
     5.2  Pharmacognostical Studies 
 Collection And Authentication of Plant 
 Preparation of Extracts 
 Qualitative Phytochemical Analysis 
 
5.3 Pharmacological Studies 
 Pylorus ligation induced ulcer model 
 Anti ulcer activity 
 Acute toxicity studies 
 
5.4 Biochemical Parameters 
  Ulcer index 
 Free acidity 
 Total acidity 
 Volume of gastric juice 
 Percentage protection 
 PH 
     5.5     Histopathological Studies 
 
28 
 
6. MATERIALS AND METHODS 
     6.1   Animals:  
  Albino wistar strain rats 
    6.2    Chemicals: 
   Petroleum ether 
   Ethanol 
   Ranitidine 
   Topfer’s reagent 
   Formalin solution 
 0.01N  sodium hydroxide 
 Dragendorff’s reagent 
 Mayer’ reagent 
 Sodium nitroprusside 
 Sodium picrate 
 Sulphuric acid 
 Alpha- Naphthol 
 Chloroform 
 Acetic anhydride 
 Sodium hydroxide 
 Copper sulphate 
 Sodium carbonate 
 Ferric chloride 
 Hydrochloric acid 
6.3 Instruments: 
 Soxhlet appararatus  
 Heating mantle 
 Round bottom flask  
 Centrifuge   
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6.4 Drug information 
Ranitidine 
Srructure : 
                     
N-2 (5 dimethy lamino) methy 1-2 fur any / methy / thioethy1-N’-methy1-2 nitro-1, 1-
3thene diamine 
Description:  
A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 
receptors).It is used to treat gastro intestinal ulcers. 
Mechanism of action:  
The H2 antagonists are competitive inhibitors of histamine at the parietal cell H2 receptor. 
They suppress the normal secretion of acid by parietal cells and the meal-stimulated secretion of 
acid. They accomplish this by two mechanisms: Histamine released by ECL cells in the stomach 
is blocked from binding an parietal cell H2 receptors which stimulate acid secretion, and other 
substances that promote secretion (such as gastrin and acetylcholine) have a reduced effect on 
parietal cells when the H2 receptros are blocked.    
Common brand names: 
Zantac, Zantac150 maximum strength, Zantac75. 
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6.5     Collection, Authentication & Drying of Plants 
6.5.1 Preliminary work 
From various articles and journals it was concluded that antioxidants can be used in the 
treatment of various diseases including peptic ulcer. Pithecellobium dulce contains antioxidant 
property so it was selected for the evaluation of Anti ulcer activity. 
6.5.2 Drying and size reduction of seeds 
The seeds of Pithecellobium dulce was dried and pulverized to coarse powder with the 
help of mixer grinder. The coarse powder was passed through sieve to maintain uniformity and 
packed into air tight container and stored in cool and dry place. This material was used for the 
further study. 
6.5.3 Extraction Process of Pithecellobium dulce seeds  
The dried coarse powder of the seeds (250G) was packed well in soxhlet apparatus and 
was subjected for continuous hot extraction. The powder mass was defatted with Petroleum 
Ether (60-80c) followed by extraction with Ethanol (90%V/V) and water by soxhelation and 
maceration respectively. The extracts were filtered and the filtrates were concentrated under 
reduced pressure to obtain the extract as solid residues.  
Pharmacognostical studies 
 6.5.4 Screening of powdered leaves 
                  Colour              -        Pale yellow 
                  Odour               -         Characteristic 
                  Taste                 -        Characteristic 
                   Texture            -         Rough 
6.5.5 Screening of Crude Extracts (Qualitative Phytochemical Analysis) 
The crude extracts obtained by solvent extraction were subjected to various qualitative 
tests to detect the presence of common chemical constituents As: 
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 Alkaloids 
 Carbohydrates And Glycosides 
 Phytosterols 
 Fixed Oil And Fats 
 Saponins 
 Tannins And Phenolic Compounds 
 Proteins And Amino Acids 
 Gums And Mucilages 
 Flavonoids  
1.  Tests For Alkaloids  
A Small Portion of the solvent free extracts were stirred separately with a few drops of 
dilute Hcl and filtered. The filtrates were tested carefully with various alkaloid reagents such as 
a) Mayer’s Test                            -        Yellow Precipitate 
b) Dragondroff’’s Reagent          -        Orange-Brown Precipitate 
c) Hager’ Test                              -        Yellow Precipitate 
d) Wagner’ Test                           -        Reddish Brown Precipitate 
 
2. Test For Carbohydrates And Glycosides 
 A Small quantity of extracts were dissolved in 5ml of distilled water and filtered. The 
filtrates were subjected to Molisch’s Test to detect the presence carbohydrates. Filtrates was 
treated with 2-3 drops of 1% alcoholic Naphtha solution and 2ml of con.H2SO4 was added along 
the sides of test tube. 
Appearance of brown Ring at the Junction of two layers showed the presence of 
carbohydrates. 
Another portion of the extract was hydrolyzed with Hcl for few hours on a water bath and 
the hydrolysate was subjected to Legal’s and Borntrager’s Test to detect the presence of different 
glycosides. 
32 
 
a) Legal’ test: To the hydrolysate 1ml pyridine and few drops of sodium nitroprusside 
solution were added and then it was made alkaline with sodium hydroxide solution. 
Appearance of pink to red colour showed the presence of glycoside and aglycones. 
b) Borntrager’s test: Hydrolysate was tested with chloroform and chloroform layer was 
separated. To this equal quantity of Dil. Ammonia solution was added. Ammonical layer 
acquired rose pink colour showed the presence of glycosides.  
3. Test for phytosterols: 
a) Salkowski test: The extract was dissolved in chloroform and equal volume of con. H2So4 
was added. Formation of bluish red to cherry colour in acid layer represented the 
steroidal components in tested extract. 
b) Liebermann-Burchard test: A small portion from each extract was taken about 1ml of 
acetic anhydride and dissolved by warming. The contents were cooled and a few drops of 
Con. H2so4 were added in each case by the sides of the test tube. Appearance of blue 
colour showed the presence of sterols. 
4. Test for Saponins:  
a) A little fraction from the various extracts were boiled with about 1 ml of distilled    water 
and shaken. Appearance of a characteristic foam formation indicated the presence of 
Saponins.    
           Aqueous and alcoholic extracts were tested directly. 
b) A little fraction from various extracts was taken with about 2ml of distilled water.  
A small quantity of sodium carbonate was added to each and shaken. The characteristic 
foam formation indicated the presence of Saponins.                                           
           Aqueous and alcoholic extract were tested directly. 
c) The extracts were diluted with 20ml of distilled water and it was agitated on a graduated 
cylinder for 15 mts. 
  Formation of foam showed the presence of Saponins. 
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5) Test for fixed oils and Fats: 
a) Small quanntities of various extracts were separately pressed between two filter papers. 
Appearance of oil stain on the paper indicates the presence of Fixed oils. 
b) Few drops of 0.5N Alcoholic potassium hydroxide was added to a small quantity of 
various extracts along with a drop of phenolphthalein. The mixture was heated on a water 
bath for 1to 2 hrs. Soap formation of foam shows the presence of fixed oils and fats. 
6)   Test for Tannins and Phenolic compounds: Small quantities of various Extracts were 
dissolved in water and tested for the presence of phenolic Compounds and  Tannins with 
dilute Ferric chloride solution(5%) - Violet colour , 1% Solution of  Gelatin containing 
10% sodium chloride – White precipitate, Lead Acetate solution – White precipitate. 
7)  Test for Flavonoids:  
a) Shinoda test: To the test solution add few magnesium turnings and con. Hydrochloric 
acid drop wise, pink scarlet, crimson red or occasionally green to blue colour appears 
after few minutes. 
b) About 5ml of each portion was boiled with distilled water and then filtered. To 2ml of the 
filtrate, few drops of 10% ferric chloride solution were then added. A green blue or violet 
coloration indicated the presence of phenolic hydroxyl group. 
c) Small quantities of various extracts were dissolved in few ml of water and treated with 
aqueous sodium hydroxide solution – Yellow color, With Con.H2s04 - Yellowish orange 
color indicates Flavones. 
8) Test for Phenolic and free Aminoacids:  
     Small quantities of various extracts were dissolved in few ml of water and Treated with 
a) Millon’s Reagent – Appearance of red colour shows the presence of Proteins and Free 
amino acids. 
b) Ninhydrin reagent – Appearance of purple colour shows the presence of Proteins and 
Free Aminoacids. 
34 
 
c) Biuret test: Equal volume of 5% sodium hydroxide solution and 1% coper suphate were 
added – Appearance of Pink to Purple colour showed the presence of Proteins and Free 
Aminoacids. 
9) Test for Gums and Mucilages: About 10ml of various extracts were added Separately to 
25ml of absolute Alcohol with constant stirring and filtered. The precipitate was dried 
and examined its swelling properties 
6.5.6 Animals 
Wistar Albino strain rats weighing between 150- 200gms were procured from the animal 
house Padmavathi college of Pharmacy. They are maintained at standard housing conditions at a 
room temperature of 240 C, relative humidity of 45-55% with 12 : 12 hour light/ dark cycle. The 
feeding was done with commercially available rat feed pellets ad water ad libitum during the 
experiment.  
Animal model used for investigation (Wistar Albino strain Rats) 
Class : Mammalia 
Family : Muridae 
Order : Rodentia 
Genus : Rattus 
Scientific name : Rattusnorve gicus     
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6.6.6 Pharmacological evaluation 
Screening of In vivo Antiulcer Activity 
Animal care and handling as per CPCSEA guideline 
                 Wistar albino strain rats of weight 150-250 grams were selected. The animals were 
acclimatized to the standard laboratory conditions in well cross ventilated animal house at 
temperature 25+ 20C relative humidity 44-56% and light and dark cycles of 12 and 12 hours 
respectively for 1week before and during the experiments. The animals were fed with standard 
diet ad water ad libitum. 
                    The experiments were approved by CPCSEA and the institutional ethics committee. 
Food was withdrawn 18 hours before the start of the activity. 
Acute oral toxicity study and selection of doses 
      A safe oral dose of EEPD and AEPD was determined through the acute oral toxic test in rats 
as described by the Organization of Economic Co-Operation and Development (OECD) as per 
423 guidelines (OECD Guidelines for the Testing of Chemicals). The EEPD&AEPD at different 
doses up to 2000mg/kg,was prepared by dissolving the extract in distilled water and the 
concentration was adjusted in such a way that it did not exceed 1ml/100g of the rat. The extract 
was then administered (p.o) and animals were observed for behavioral changes, any toxicity and 
mortality up to 48 h. The doses (250 mg/kg,p.o) of EEPD and AEPD were later chosen for this 
study based on the acute toxicity testing. 
Experimental Design 
6.6.7 Pylorus Ligation Induced Ulcer Model                       
Wistar albino strain rats weighing 150-20g were selected for pyloric ligation ulcer model. 
Rats were divided into five groups, each group consisting of six animals. Animals were fasted 
for 48 hours. 
 Group-I: Normal  
 Group-II: Control (Saline 2ml/kg) 
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 Group-III: Treated with Ranitidine50mg/kg 
 Group-IV: Treated with AEPD (100mg/kg) 
 Group-V: Treated with EEPD (100mg/kg) 
The oral treatment was carried out 1 hour before pyloric ligation, respectively. After 48 hours of 
fasting, ulcer induction was undertaken according to Shay et al. 
The rats were mildly anaesthetized with Anesthetic Ether and the abdomen was cut open 
through a midline incision. The pylorus was secured and ligated with silk sutures, after which 
the wound was closed and the animals were allowed to recover from anesthesia. After ligation 
of the pylorus, drinking water was withheld and the gastric examinations were under taken 18 
hours after pylorus ligation. The animals were sacrificed with an overdose of Anesthetic Ether 
and the stomach were opened along the greater curvature, rinsed with saline to remove gastric 
contents and blood clots and examined by a magnifier lens (10x) to assess the formation of ulcer 
as shown in figure 1. 
Using transpires surgical tapes assessed ulcer area, which was fixed on a light and 
transparent sheet and the ulcer area was measured for each stomach. The number of erosions 
formed on glandular portion of the stomach was counted and each was given a severity rating 
on a 1-3 scale. The gastric contents were collected and centrifuged at 1000RPM for 10 min. One 
ml of the supernatant liquid was pipette out and diluted to 10 ml with distilled water. The 
solution was titrated against 0.01N NaOH using Topfer’s reagent as an indicator, to the 
endpoint when the solution turned to orange colour.The volume of NaOH needed was taken as 
corresponding to the free acidity. Titration was further continued till the solution regained pink 
color. The volume of NaOH required was noted and was taken as corresponding to the total 
acidity.    
Ulcer index will be then calculated by adding the total number of ulcers per stomach and 
the total severity of ulcers per stomach. 
Scoring of ulcer will be made as follows 
No ulcer                              (0) 
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Superficial ulcers                (1) 
Deep ulcers                         (2) 
Perforation                          (3)      
Mean ulcer score for each animal will be expressed as ulcer index- 
U1= UN + Us + UP X 10-1 
Where  
U1= Average of number of ulcers per animal 
Us= Average of severity of score 
Up= Percentage of animals with ulcers 
The percentage of ulcer protection will be determined as follows- 
                                               Control mean ulcer index – Test mean ulcer index     
           % Protective   =                                                                                                     X 100 
                                                               Control mean ulcer index 
 
Reagents for biochemical estimations of free and total acidity 
Reagents for estimation of free and total acidity 
a) Freshly prepared 0.01N oxalic acid solution was used to standardize sodium hydroxide. 
b) Freshly prepared 0.01N Sodium Hydroxide 
c) Topfer’ reagent. It is dimethyl amino azo benzene 0.5% in absolute ethanol available in 
100ml package. 
d) Freshly prepared 1% phenolphthalein solution prepared in 50% absolute ethanol. 
Methods for biochemical estimation of free and total acidity. 
Collection of gastric juice 
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Gastric contents collected from pylorus ligated rats was centrifuged and the volumes of 
gastric juice were noted. The gastric juice was subjected to biochemical estimation as follows. 
Determination of free and total acidity 
1ml of gastric juice was pipette into a100ml conical flask, 2or 3 drops of Topfer’s reagent 
was added and titrated with 0.01N Sodium hydroxide until all traces of red color disappears and 
the color of the solution turns to yellowish orange. The volume of alkali added was noted. This 
volume corresponds to free acidity. Then 2or3 drops of phenolphthalein solution were added and 
titration was continued until a definite red tinge appears. Again the total volume of alkali added 
was noted now this volume corresponds to total acidity. 
Acidity was calculated by using the formula 
                     Volume of NaoH x Normality of NaoH x 100 
Acidity =                                                                                                        meq/lt/100g 
                                                 0.1 
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Statistical Analysis    
The Statistical analysis was performed by One Way ANOVA followed by Dunnet’s 
comparison test and Student- New man- keuls test. The values are expressed as Mean +SEM.                       
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7. RESULTS & DISCUSSION 
7.1 EXTRACTION 
The extraction value of EEPD 
Total Amount of crude drug used = 250gm 
Amount obtained as Ethanolic Extract = 23gm 
% Yield = 23/250 x 100 
               = 9.2% W/W 
The extraction value of AEPD                       
Total Amount of crude drug used = 230gm 
Amount obtained as Ethanolic Extract = 21gm 
% Yield = 21/230 x 100 
               = 9.1% W/W 
                                     
Table: 2 Percentage Yield 
 
Plant name 
 
Part used 
 
Method of extraction 
 
Percentage yield 
Pithecellobium dulce       Seed    Soxhlet extraction 9.2%w/w 
Pithecellobium dulce       Seed     Maceration 9.1%w/w 
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  7.2 PRELIMINARY PHYTOCHEMICAL SCREENING    
   The Extracts of Pithecellobium dulce was subjected for phytochemical screening and 
found that Saponins, Sterols, Glycosides, Flavonoids, Fixed oils and Fats, Gums and Mucilages 
were present. The results were as follows. 
  
Table 3: Phytochemical screening tests and results 
S.No Group Ethanolic Extract Aqueous Extract 
1. Alkaloids           _           _ 
2. Saponins           +            _ 
3. Sterols           +             + 
4. Glycosides           +           +  
5. Flavonoids           +           + 
6. Fixed oils and Fats           +           _ 
7. Tannins and phenolic compounds           _           _ 
8. Proteins and Aminoacids           _           _ 
9. Gums and Mucilages           +           + 
 
(+)  indicates Presence (-) indicates Absence 
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  7.3  Macroscopical view of pylorus ligation induced ulcer 
         
                            
a) Normal 
b) Control 
c) Standard 
d) Ethanolic extract of pithecellobium dulce 
e) Aqueous extract of pithecellobium dulce 
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7.3 PHARMACOLOGICAL SCREENING 
7.3.1 Pylorus ligation induced ulcer: 
Effect of EEPD and AEPD on ulcer index in pylorus ligation induced ulcer (Table no 
7.3.1.1) 
Group Treatment Dose(mg/kg) Ulcer index 
(mm2/rat) 
% Protection 
I. Normal 2 1.60 -- 
II. Control 2 9.03 -- 
III. Standard 50 1.76 80.5 
IV. EEPD 100 3.63* 59.8* 
V. AEPD 100 4.03* 60.8* 
Values are expressed as (Mean ± S.E.M.), n=5, *p< 0.05 when compared with control group. 
(Statistically analyzed by one-way analysis of variance  (ANOVA) followed by Dunnet’s t-test.) 
Results were considered to be statistically significant at P<0.05. 
  
 
PYLORUS LIGATION MODEL ULCER INDEX
1.6
9.03
1.76
3.63
4.03
0
1
2
3
4
5
6
7
8
9
10
Normal Control Standard EEPD AEPD
 
 
 
Effect of EEPD and AEPD on ulcer index in pylorus ligation induced ulcer 
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   Effect of Pithecellobium dulce seed Ethanolic extract on volume of gastric juice, Total     
   acidity and Free acidity in Pylorus ligation induced ulcer.   (Table no 7.3.1.2)                                                              
Group Treatment 
Dose 
(mg/kg) 
p.o 
Volume of 
gastric 
juice 
 
PH 
Free 
Acidity 
(mEq/L) 
Total 
Acidity 
(mEq/L) 
   I Normal 2 3.1±0.23 4.1 5.4±0.08 7.6±0.2 
  II Control 2 4.2±0.18 2.8 4.6±0.05 22.3±0.3 
  III Standard 50 1.9±0.07 7.5 3.1±0.02 6.8±0.16 
  IV EEPD 100 2.4±0.11* 6.9 3.4±0.03* 5.9±0.12* 
Values are expressed as (Mean ± S.E.M.), n=5, *p< 0.05 when compared with control group. 
(Statistically analyzed by one-way analysis of variance  (ANOVA) followed by Dunnet’s t-test.) 
Results were considered to be statistically significant at P<0.05.  
 
 
PYLORUS LIGATION MODEL ULCER INDEX 
1.6 
9.03 
1.76 
3.63 
0 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Normal Control Standard EEPD 
Effect of EEPD on ulcer index in pylorus ligation induced ulcer model 
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Effect of Pithecellobium dulce seed Aqueous extract on volume of gastric juice, Total     
   Acidity and Free acidity in Pylorus ligation induced ulcer.        (Table no 7.3.1.3)                                                    
 
 
Values are expressed as (Mean ± S.E.M.), n=5, *p< 0.05 when compared with control group. 
(Statistically analyzed by one-way analysis of variance (ANOVA) followed by Dunnet’s t-test.) 
Results were considered to be statistically significant at P<0.05. 
  
Group Treatment 
Dose 
(mg/kg) 
p.o 
Volume of 
gastric juice 
 
PH 
Free Acidity 
(mEq/L) 
Total 
Acidity 
(mEq/L) 
   I Normal 2 3.1±0.23 4.1 5.4±0.08 7.6±0.2 
  II Control 2 4.2±0.18 2.8 4.6±0.05 22.3±0.3 
  III Standard 50 1.9±0.07 7.5 3.1±0.02 6.8±0.16 
   IV AEPD 100 1.5±o.28* 6.4 2.1±0.18* 6.3±0.27 
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Effect of AEPD on ulcer index in pylorus ligation induced ulcer model 
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Histopathological analysis of pylorus ligation induced ulcer model 
     
Fig:1 Stomach of normal rat                                 Fig:2 Stomach of control rat showing erosion in   
                                                                               the upper part of epithelium with RBCs in  
                                                                               Eroded portion    
  
    
Fig: 3 Stomach of rat treated with ranitidine      Fig: 4 Stomachs of EEPD treated rats showing  
Showing small erosions with minimum             small superficial erosion with minimum deviation     
Deviation from normal morphology                    from normal morphology 
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Fig: 5 Stomachs of AEPD treated rats showing small superficial erosion with minimum deviation 
from normal morphology 
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DISCUSSION 
Peptic ulcer and gastritis have been associated with multi pathogenic factors and could be 
due to disturbances in natural balances between the aggressive factors (e.g. of acid, bicarbonate, 
pepsin) and maintenance of the mucosal integrity through the endogenous defense mechanism. 
Generally various non specific methods are used to restore these imbalances including regular 
food intake, adequate rest, and avoidance of ulcerogenic agents (e.g. tobacco, alcohol and 
coffee).Their aims are to attenuate and possibly block the gastric acid secretion or to enhance the 
mucosal defense mechanisms. The latter can be achieved through increasing mucus production, 
stabilizing the surface epithelial cells, or interfering with the prostaglandin synthesis. In addition 
there are also drugs, such as pump inhibitors, histamine (H2)-antagonists, anti cholinergics and 
antacids, used in the treatment of ulcer. 
The H2 receptor is a G protein coupled receptor (GPCR) that activates the Gs-
adenylcyclase-cyclic AMP-PKA pathway. The H2 Receptor antagonists inhibit acid production 
by reversibly competing with histamine for binding to H2 receptors on the basolateral membrane 
of parietal cells. Four different H2 –receptor antagonists, which differ mainly in their 
pharmacokinetics and propensity to cause drug interactions, are available in the United States: 
cimetidine (TAGAMET), Ranitidine (ZANTAC), famotidine (PEPCID),and nizatidine(AXID). 
These drugs are less potent than proton pump inhibitors but still suppress 24-hour gastric acid 
secretion by about 70%. We evaluated effects of ethanolic and aqueous extracts obtained from 
Pithecellobium dulce seeds in animals using the different standard experimental models of 
induced gastric ulcers. In case of Pylorus ligation model, The total acidity was decreased. 
Circular and linear lesions were frequently observed in the stomach of all the control animals. 
Administration of Pithecellobium dulce extracts resulted in a significant reduction in ulcer index 
in dose dependent manner when compared to control, despite the availability of many 
pharmaceutical products for the treatment of gastric ulcers in the market as mentioned above, 
their successes were limited by presence of several adverse effects (e.g. anaphylaxis reactions, 
gynecomastia, hematopoietic changes, thrombocytopenia, acute interstial nephritis, 
nephrotoxicity and hepatotoxicity). Due to the reported side effects of available antiulcer drugs, 
focused have been shifted towards natural products as the new sources of antiulcer agents. 
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Pithecellobium dulce   has been reported to exert several pharmacological properties such 
as antimicrobial, anti inflammatory, antibacterial, antioxidant, antidiabetic, hepatoprotective, 
activities. Despite claim of its potential in the treatment of gastric ulcer, this plant so for not been 
screened for anti-ulcer potential activity. Thus, we take this opportunity to report the preliminary 
findings on anti ulcer potential of Pithecellobiumdulce seed extracts for the first time here. The 
present study demonstrated the potential of EEPD and AEPD to significantly reduced gastric 
ulceration as indicated by the reduction in ulcer index in the pylorus induced assays. Based on 
further findings using the PL assay, the extracts was suggested to act by reducing the volume of 
gastric juice secreted, gastric free and total acidities. These results suggested that EEPD and 
AEPD possess anti-secretory potency as well s acid neutralizing effect. It is also possible to 
suggest that the observed antiulcer activity associated with P.dulce is the ability to exhibit 
antioxidant activity cited above. Oxidative stress, resulting from the increase production of 
oxygen derived free radicals (e.g. superoxide anion, hydrogen peroxide and hydroxyl radicals), 
has been known to take part in the pathogenesis of various diseases including gastric ulcer and 
antioxidants help to protect cells from damage elicited by oxidative stress while enhancing the 
body’s defence systems against degenerative diseases. 
P.dulce seed extract had been reported to possess antioxidant activity and to contain 
various types of compounds such as flavonoids, saponins, sterols, carbohydrates, glycosides, 
lipids, fixed oils and fats, gums and mucilages. The anti ulcer activity is probably due to the 
presence of bioactive compound like flavonoids. Statistical analysis revealed that ethanolic and 
aqueous extracts of Pithecellobium dulce contains antiulcer activity due to the presence of 
flavonoids and sterol.  
In the histopathological examination, stomachs of control rat shows erosion in the 
upper part of epithelium and RBCs are seen in the eroded portion (Fig 2), stomachs of rats 
treated with standard drug (ranitidine) showed small erosions with a minimal deviation from nor-
mal morphology, (Fig 3). Stomachs of rats treated with EEPD extract showed small superficial 
erosion with minimal deviation from normal morphology, (Fig 4) and stomachs of rats treated 
with AEPD extract showed superficial erosions with minimum dev-iations from normal 
morphology (Fig 5).       
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Effect of EEPD and AEPD in pylorus ligated rats 
 Pylorus ligation in ulcerated control group had produced ulcer in all animals and the 
mean ulcer index was 9.03 indicating the ulcerogenic effect. Mean gastric content volume as 
4.2±0.18,free acidity as 4.6±0.05,total acidity as 22.3±0.3 indicating the ulcer production in 
animal. However the ulcer index showed significant dose dependent reduction in the animal pre 
treated with EEPD 100mg/kg(UI; 3.63) and with AEPD 100mg/kg(UI;4.03). It indicated 59.8% 
gastro protection with EEPD 100mg/kg and 60.8% with AEPD 100mg/kg as compared with 
ulcerated control. The results indicate that AEPD 100mg/kg was effective in protecting ulcers in 
pylorus ligated rats. Pylorus ligation had produce ulcers in all animals pre treated with Ranitidine 
50mg/kg. However, ulcer index (1.76) showed significant reduction as compared with ulcerated 
control and showed 80.5% gastro protection.  
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8. CONCLUSION 
  
        Here present study was carried out to investigate anti-ulcer activity of Ethanolic and 
Aqueous extracts of Pithecellobium dulce seeds in pylorus ligation induced ulcer in the Wistar 
albino strain rats. It has not produced any lethal effect up to the dose level of 2000mg/kg during 
acute toxicity testing. The Aqueous extract of Pithecellobium dulce showed significant Anti 
ulcer activity. Pithecellobium dulce belongs to the family Mimosoideae and the qualitative 
photochemical study reveals the presence of saponins, sterols, glycosides, flavonoids, fixed oils 
and fats, gums and mucilage.  
       The present study provided preliminary data for the first time that the seeds of 
Pithecellobium dulce possess significant anti ulcer activity in animal models. It has a gastric anti 
secretary effect that is comparable to reference drug Ranitidine. The anti ulcer activity is 
probably due to presence of bioactive compounds like Flavonoids and sterol. The observation 
justifies the ethanomedical uses of the plant as anti ulcer agent and as antacid in addition to its 
nutritional values. Histopathological studies of the stomach in pylorus ligation models exhibit 
normal architecture of stomach tissue. This protective effect might have been mediated by both 
anti-secretary and cytoprotective mechanisms .Standard dose of Ranitidine and Extracts of 
Pithecellobium dulce significantly decreased the gastric volume, total acidity, free acidity and 
ulcer index. Among the extracts AEPD with 100mg/kg is more effective compared to EEPD 
100mg/kg. So I concluded that my plant Pithecellobium dulce possessing Anti ulcer activity 
according to the data and further research work can be carried out to different formulations. 
However there is a shortage of clinical trial regarding its potency and efficacy. 
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